ICOSLG and diabetes mellitus: In order to address these issues in the present model, we investigated whether T-cells from ICOSL+/+ or ICOSL−/− NOD donors could transfer diabetes or neuromyopathy to conventional NOD.scid or ICOSL−/− NOD.scid recipients.